Michael Dechant

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Sven Berger et al. · The Journal of Immunology · 2009 · 216 citations · Full text

Immune Regulation, Immunology, Cell Death +20

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells

Matthias Peipp, Jeroen J. Lammerts van Bueren, Tanja Schneider‐Merck et al. · Blood · 2008 · 214 citations · Full text

Immunotoxicology, Immunology, Immune Regulation +16

Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies

Michael Dechant, Wencke Weisner, Sven Berger et al. · Cancer Research · 2008 · 162 citations

Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors

Marielle A. Otten, Esther Rudolph, Michael Dechant et al. · The Journal of Immunology · 2005 · 147 citations · Full text

CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

Lutz Renders, M Frisman, Mike Ufer et al. · Clinical Pharmacology & Therapeutics · 2006 · 130 citations